Watch Intently (one)pentobarbital will lessen the extent or impact of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. CYP3A4 inducers have not been researched, coadministration not proposed by company
pentobarbital will lessen the level or result of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
pentobarbital will minimize the level or influence of dienogest/estradiol valerate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Women must not decide on estradiol valerate/dienogest as their contraceptive though using powerful CYP3A4 inducers due to probable minimize in contraceptive efficacy.
pentobarbital will lower the extent or influence of alfuzosin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital will lower the level or effect of iloperidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
Watch Closely (1)pentobarbital will minimize the extent or impact of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the extent or result of glecaprevir/pibrentasvir by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the level or impact of apremilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with strong CYP inducers results in a substantial lower of systemic publicity of apremilast, which can end in lack of efficacy
pentobarbital will lessen the extent or influence of vardenafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the level or result of diazepam intranasal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Powerful or reasonable CYP3A4 inducers may well maximize rate of diazepam elimination; as a result, efficacy of diazepam could possibly be reduced.
Contraindicated (one)pentobarbital decreases amounts of vandetanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration with strong CYP3A4 inducers; these drugs reduce exposure to vandetanib by up to forty%.
pentobarbital decreases levels of vandetanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Avoid coadministration with powerful CYP3A4 inducers; these drugs decrease publicity to vandetanib by as much as forty%.
pentobarbital will minimize the level or impact of buprenorphine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will decrease the extent or result of cyclosporine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. check here Use Caution/Observe.